REG - Carclo plc - Banking covenant update

CarcloAnnouncement

18/07/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230718:nRSR2889Ga&default-theme=true

RNS Number : 2889G  Carclo plc  18 July 2023

 

18 July 2023

 

Carclo plc

 

("Carclo" or the "Group")

 

 

Banking Covenant Adjustment - Update

 

 

Carclo is pleased to confirm that the agreement made with its lending bank to
amend banking covenants, as previously announced on 23 June 2023, has now been
formally signed.

 

In the unaudited preliminary accounts for Carclo, for the year ending on 31
March 2023 and released on 12 July 2023, a material uncertainty over going
concern was noted due to the fact that the formal documentation for the
covenant adjustment was yet to be signed.  It is now the view of the
directors, that following the formal signing of the revised covenant
agreement, that this uncertainty is removed.

 

As previously announced, the Group expects to publish its audited full
consolidated financial statements for the year ended 31 March 2023, on or
before 31 July 2023.

 

 

Enquiries:

Carclo plc                             01924
268040

Frank Doorenbosch - Chief Executive Officer

David Bedford - Chief Financial Officer

 

LEI: 21380078MEM399JPI956

 

This announcement contains information that qualifies or may qualify as inside
information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it
forms part of UK domestic law by virtue of the European Union (Withdrawal)
Act 2018 ("MAR").

 

 

 

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of
the London Stock Exchange. The Group  is a preferred and trusted partner of
global customers, offering high-precision critical components that meet the
needs of life sciences, aerospace, optics, and technology industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDFLFVDDEIDLIV